Loading...
Loading...
Application UK00906898613 · Registered
| Application Number | UK00906898613 |
| Status | Registered |
| Owner | Neurodyn Life Sciences Inc. |
| Filed | 2008-05-08 |
| Registered | 2009-04-07 |
| Renewal Due | 2028-05-08 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. Memogain is currently a registered UK trademark, with renewal due on 2028-05-08. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical, veterinary and sanitary preparations; pharmaceutical preparations and products for treating diseases and disorders of the central nervous system, for the treatment of Alzheimer's disease, for the treatment of other dementias, Parkinson's disease, nootropics, schizophrenia preparations and other psychotropics, anti-depressives, geriatric preparations, acetylcholinesterase inhibitors, cholinergic enhancers, cholinomimetics.
Pharmaceutical research and development services.
'Memogain' is a registered trademark on the UK IPO register, owned by Neurodyn Life Sciences Inc.. The application (UK00906898613) was filed on 8 May 2008 and registered on 7 April 2009. The registration is set to expire on 8 May 2028.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services).
The trademark is represented by Maguire Boss.
UK trademark UK00906898613 for the mark 'Memogain' in Class 5, 42 is recorded on the UK IPO register as owned by Neurodyn Life Sciences Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00906898613 for the mark 'Memogain' as registered.
UK trademark UK00906898613 for the mark 'Memogain' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical, veterinary and sanitary preparations; pharmaceutical preparations and products for treating diseases and disorders of the central nervous system, for the treatment of Alzheimer's disease, for the treatment of other dementias, Parkinson's disease, nootropics, schizophrenia preparations and ot…
UK trademark UK00906898613 for the mark 'Memogain' was filed at the UK IPO on 8 May 2008 and registered on 7 April 2009.
UK trademark UK00906898613 for the mark 'Memogain' is currently recorded as valid until 8 May 2028, at which point it will need to be renewed with the UK IPO to remain in force.
Maguire Boss is listed as the attorney / representative of record for UK trademark UK00906898613 for the mark 'Memogain' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "Memogain" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| MEMOGAINSame applicant | 87507548 | 606 | 2017-06-27 |
| MEMOGAIN | 97177110 | 602 | 2021-12-17 |
| MEMOGAIN | 79082720 | 404 | 2010-04-15 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.